BioSpace News Archive

Catalent, Inc. announced that it will release financial results for the first quarter of fiscal year 2023 ended September 30, 2022, before the market open on Tuesday, November 1, 2022.

Nortech Systems Incorporated, a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical, aerospace & defense and industrial markets, will hold a live conference call and webcast at 4:00 p.m. central time on Thursday, November 10, 2022, to discuss the company’s third quarter financial results.

InxMed Co., Ltd is pleased to announce that the clinical data from an open-label, phase Ib trial evaluating the efficacy and safety of IN10018, a highly potent and selective oral inhibitor of focal adhesion kinase, alone or in combination with cobimetinib in patients with Uveal Melanoma and NRAS-mutant melanoma.